Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 24

Trial Status

Completed6
Terminated3

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT00134888Not ApplicableCompleted
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
Opioid-Related Disorders
Principalinvestigator
NCT00142727Phase 2Terminated
Opioid Agonist and Antagonist Effects on Opioid Dependence
Opioid-Related Disorders
Principalinvestigator
NCT00142779Not ApplicableCompleted
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
Cocaine-Related DisordersOpioid-Related Disorders
Principalinvestigator
NCT00142896Phase 2Completed
Tramadol to Reduce Opioid Withdrawal Symptoms
Opioid-Related Disorders
Principalinvestigator
NCT00149539Phase 2Terminated
Abuse Potential of Buprenorphine/Naloxone
Opioid-Related Disorders
Principalinvestigator
NCT00158236Not ApplicableCompleted
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
Opioid-Related Disorders
Principalinvestigator
NCT00301210Phase 1/2Completed
Assessment of Tramadol as a Treatment for Opioid Addiction
Opioid-Related Disorders
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Johns Hopkins University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Eugene Somoza, M.D., Ph.D.

Cincinnati MDRU

Moderately Similar
7 trials

Shared therapeutic areas:

Cocaine-Related DisordersOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Walter Ling, M.D.

Friends Research Institute, Inc.

Moderately Similar
28 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Mark Greenwald, PhD

Wayne State University

Moderately Similar
15 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Warren Bickel, Ph.D.

University of Vermont

Moderately Similar
22 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Kenneth Silverman, Ph.D.

Johns Hopkins University

Moderately Similar
8 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)
Similarity Score30%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Moderately Similar
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Moderately Similar
10 trials

Shared therapeutic areas:

Cocaine-Related DisordersOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Herbert Kleber, M.D.

New York State Psychiatric Institute

Moderately Similar
9 trials

Shared therapeutic areas:

Cocaine-Related DisordersOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Charles O'Brien, M.D., Ph.D.

PDVAMC Treatment Research Center

Related
7 trials

Shared therapeutic areas:

Opioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Elizabeth Ralevski, Ph.D.

Yale University

Related
6 trials

Shared therapeutic areas:

Opioid-Related Disorders
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT00000243Not ApplicablePrincipalInvestigator

Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone

Opioid-Related Disorders
Terminated
NCT00134888Not ApplicablePrincipalInvestigator

Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence

Opioid-Related Disorders
Completed
NCT00134914Not ApplicablePrincipalInvestigator

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders
Completed
NCT00142727Phase 2PrincipalInvestigator

Opioid Agonist and Antagonist Effects on Opioid Dependence

Opioid-Related Disorders
Terminated
NCT00142779Not ApplicablePrincipalInvestigator

Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts

Cocaine-Related DisordersOpioid-Related Disorders
Completed
NCT00142896Phase 2PrincipalInvestigator

Tramadol to Reduce Opioid Withdrawal Symptoms

Opioid-Related Disorders
Completed
NCT00149539Phase 2PrincipalInvestigator

Abuse Potential of Buprenorphine/Naloxone

Opioid-Related Disorders
Terminated
NCT00158236Not ApplicablePrincipalInvestigator

Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users

Opioid-Related Disorders
Completed
NCT00301210Phase 1/2PrincipalInvestigator

Assessment of Tramadol as a Treatment for Opioid Addiction

Opioid-Related Disorders
Completed

All 9 trials loaded